Back to company

NBCD A/S: Financial statements 2019

CVR: 30582462

NBCD A/S (CVR 30582462) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 48,913,734 and a net result of DKK 33,733,642 compared with DKK 16,252,006 the year before. That is an increase of 82.9% compared with the year before. Equity amounted to DKK 36,486,238. The solvency ratio was 41.4%. The company had 20 employees in the financial year.

Gross Profit
48,913,734 kr.
Profit/Loss
33,733,642 kr.
Equity
36,486,238 kr.
Total Assets
88,130,177 kr.
Employees
20

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-48.9 mio.33.7 mio.36.5 mio.20
2018-26.7 mio.16.3 mio.17.8 mio.25
2017-24.6 mio.20.8 mio.21.5 mio.-
2016-12.7 mio.14 mio.9.7 mio.-
2015--6.1 mio.37.9 mio.44.2 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

NBCD A/S: The 2018 annual report is outJun 8, 2019

NBCD A/S has published its annual report for 2018. Gross profit came to DKK 26,749,241, and the net result was DKK 16,252,006.

About NBCD A/S

NBCD A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2007. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named NORDIC BIOSCIENCE CLINICAL DEVELOPMENT A/S and NORDIC BIOSCIENCE PROJECT 2 A/S. The management consists of Jeppe Ragnar Andersen and Mark Høgh Gandrup. The company is owned by Sanos Holding A/S. The company has 24 employees. In 2025, the company reported a gross profit of DKK 31,583,144 and a net result of DKK 9,222,892 compared with DKK 52,621,101 the year before. Equity amounted to DKK 136,144,994.